Donepezil

Overview

Donepezil, also called Aricept, a centrally acting reversible acetyl cholinesterase inhibitor that the FDA has also approved for the treatment of moderate to severe Alzheimer's disease. It readily crosses the blood-brain barrier to reduce the breakdown of acetylcholine by increasing the concentration of acetylcholine through reversible inhibition of its hydrolysis by acetylcholinesterase.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Alzheimer's disease | AChE

Product Information

• Catalog No.: B2692-082304
• CAS No.: 120014-06-4
• Molecular Formula: C24H29NO3
• Molecular Weight: 379.49
• Purity: > 98%
• Storage: -20 °C
• Solubility: Slightly soluble in Acetone, Chloroform, Water (2.93 mg/L at 25 °C )

Source

Original product source